Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study

The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning techniques may offer more powerful means to predict disease course in MS patients. In our study, 724 patients from the Comprehensive Longitudinal Investigation in MS at Brigham and Women’s Hospital (...

Full description

Saved in:
Bibliographic Details
Published in:NPJ digital medicine Vol. 3; no. 1; pp. 135 - 8
Main Authors: Zhao, Yijun, Wang, Tong, Bove, Riley, Cree, Bruce, Henry, Roland, Lokhande, Hrishikesh, Polgar-Turcsanyi, Mariann, Anderson, Mark, Bakshi, Rohit, Weiner, Howard L., Chitnis, Tanuja
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 16.10.2020
Nature Publishing Group
Nature Portfolio
Subjects:
ISSN:2398-6352, 2398-6352
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning techniques may offer more powerful means to predict disease course in MS patients. In our study, 724 patients from the Comprehensive Longitudinal Investigation in MS at Brigham and Women’s Hospital (CLIMB study) and 400 patients from the EPIC dataset, University of California, San Francisco, were included in the analysis. The primary outcome was an increase in Expanded Disability Status Scale ( EDSS ) ≥ 1.5 (worsening) or not (non-worsening) at up to 5 years after the baseline visit. Classification models were built using the CLIMB dataset with patients’ clinical and MRI longitudinal observations in first 2 years, and further validated using the EPIC dataset. We compared the performance of three popular machine learning algorithms ( SVM, Logistic Regression, and Random Forest ) and three ensemble learning approaches ( XGBoost, LightGBM , and a Meta-learner L ). A “threshold” was established to trade-off the performance between the two classes. Predictive features were identified and compared among different models. Machine learning models achieved 0.79 and 0.83 AUC scores for the CLIMB and EPIC datasets, respectively, shortly after disease onset. Ensemble learning methods were more effective and robust compared to standalone algorithms. Two ensemble models, XGBoost and LightGBM were superior to the other four models evaluated in our study. Of variables evaluated, EDSS, Pyramidal Function , and Ambulatory Index were the top common predictors in forecasting the MS disease course. Machine learning techniques, in particular ensemble methods offer increased accuracy for the prediction of MS disease course.
AbstractList The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning techniques may offer more powerful means to predict disease course in MS patients. In our study, 724 patients from the Comprehensive Longitudinal Investigation in MS at Brigham and Women's Hospital (CLIMB study) and 400 patients from the EPIC dataset, University of California, San Francisco, were included in the analysis. The primary outcome was an increase in Expanded Disability Status Scale (EDSS) ≥ 1.5 (worsening) or not (non-worsening) at up to 5 years after the baseline visit. Classification models were built using the CLIMB dataset with patients' clinical and MRI longitudinal observations in first 2 years, and further validated using the EPIC dataset. We compared the performance of three popular machine learning algorithms (SVM, Logistic Regression, and Random Forest) and three ensemble learning approaches (XGBoost, LightGBM, and a Meta-learner L). A "threshold" was established to trade-off the performance between the two classes. Predictive features were identified and compared among different models. Machine learning models achieved 0.79 and 0.83 AUC scores for the CLIMB and EPIC datasets, respectively, shortly after disease onset. Ensemble learning methods were more effective and robust compared to standalone algorithms. Two ensemble models, XGBoost and LightGBM were superior to the other four models evaluated in our study. Of variables evaluated, EDSS, Pyramidal Function, and Ambulatory Index were the top common predictors in forecasting the MS disease course. Machine learning techniques, in particular ensemble methods offer increased accuracy for the prediction of MS disease course.The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning techniques may offer more powerful means to predict disease course in MS patients. In our study, 724 patients from the Comprehensive Longitudinal Investigation in MS at Brigham and Women's Hospital (CLIMB study) and 400 patients from the EPIC dataset, University of California, San Francisco, were included in the analysis. The primary outcome was an increase in Expanded Disability Status Scale (EDSS) ≥ 1.5 (worsening) or not (non-worsening) at up to 5 years after the baseline visit. Classification models were built using the CLIMB dataset with patients' clinical and MRI longitudinal observations in first 2 years, and further validated using the EPIC dataset. We compared the performance of three popular machine learning algorithms (SVM, Logistic Regression, and Random Forest) and three ensemble learning approaches (XGBoost, LightGBM, and a Meta-learner L). A "threshold" was established to trade-off the performance between the two classes. Predictive features were identified and compared among different models. Machine learning models achieved 0.79 and 0.83 AUC scores for the CLIMB and EPIC datasets, respectively, shortly after disease onset. Ensemble learning methods were more effective and robust compared to standalone algorithms. Two ensemble models, XGBoost and LightGBM were superior to the other four models evaluated in our study. Of variables evaluated, EDSS, Pyramidal Function, and Ambulatory Index were the top common predictors in forecasting the MS disease course. Machine learning techniques, in particular ensemble methods offer increased accuracy for the prediction of MS disease course.
Abstract The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning techniques may offer more powerful means to predict disease course in MS patients. In our study, 724 patients from the Comprehensive Longitudinal Investigation in MS at Brigham and Women’s Hospital (CLIMB study) and 400 patients from the EPIC dataset, University of California, San Francisco, were included in the analysis. The primary outcome was an increase in Expanded Disability Status Scale (EDSS) ≥ 1.5 (worsening) or not (non-worsening) at up to 5 years after the baseline visit. Classification models were built using the CLIMB dataset with patients’ clinical and MRI longitudinal observations in first 2 years, and further validated using the EPIC dataset. We compared the performance of three popular machine learning algorithms (SVM, Logistic Regression, and Random Forest) and three ensemble learning approaches (XGBoost, LightGBM, and a Meta-learner L). A “threshold” was established to trade-off the performance between the two classes. Predictive features were identified and compared among different models. Machine learning models achieved 0.79 and 0.83 AUC scores for the CLIMB and EPIC datasets, respectively, shortly after disease onset. Ensemble learning methods were more effective and robust compared to standalone algorithms. Two ensemble models, XGBoost and LightGBM were superior to the other four models evaluated in our study. Of variables evaluated, EDSS, Pyramidal Function, and Ambulatory Index were the top common predictors in forecasting the MS disease course. Machine learning techniques, in particular ensemble methods offer increased accuracy for the prediction of MS disease course.
The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning techniques may offer more powerful means to predict disease course in MS patients. In our study, 724 patients from the Comprehensive Longitudinal Investigation in MS at Brigham and Women's Hospital (CLIMB study) and 400 patients from the EPIC dataset, University of California, San Francisco, were included in the analysis. The primary outcome was an increase in ( ) ≥ 1.5 (worsening) or not (non-worsening) at up to 5 years after the baseline visit. Classification models were built using the CLIMB dataset with patients' clinical and MRI longitudinal observations in first 2 years, and further validated using the EPIC dataset. We compared the performance of three popular machine learning algorithms ( and ) and three ensemble learning approaches ( , and a Meta-learner ). A "threshold" was established to trade-off the performance between the two classes. Predictive features were identified and compared among different models. Machine learning models achieved 0.79 and 0.83 AUC scores for the CLIMB and EPIC datasets, respectively, shortly after disease onset. Ensemble learning methods were more effective and robust compared to standalone algorithms. Two ensemble models, XGBoost and LightGBM were superior to the other four models evaluated in our study. Of variables evaluated, EDSS, , and were the top common predictors in forecasting the MS disease course. Machine learning techniques, in particular ensemble methods offer increased accuracy for the prediction of MS disease course.
The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning techniques may offer more powerful means to predict disease course in MS patients. In our study, 724 patients from the Comprehensive Longitudinal Investigation in MS at Brigham and Women’s Hospital (CLIMB study) and 400 patients from the EPIC dataset, University of California, San Francisco, were included in the analysis. The primary outcome was an increase in Expanded Disability Status Scale ( EDSS ) ≥ 1.5 (worsening) or not (non-worsening) at up to 5 years after the baseline visit. Classification models were built using the CLIMB dataset with patients’ clinical and MRI longitudinal observations in first 2 years, and further validated using the EPIC dataset. We compared the performance of three popular machine learning algorithms ( SVM, Logistic Regression, and Random Forest ) and three ensemble learning approaches ( XGBoost, LightGBM , and a Meta-learner L ). A “threshold” was established to trade-off the performance between the two classes. Predictive features were identified and compared among different models. Machine learning models achieved 0.79 and 0.83 AUC scores for the CLIMB and EPIC datasets, respectively, shortly after disease onset. Ensemble learning methods were more effective and robust compared to standalone algorithms. Two ensemble models, XGBoost and LightGBM were superior to the other four models evaluated in our study. Of variables evaluated, EDSS, Pyramidal Function , and Ambulatory Index were the top common predictors in forecasting the MS disease course. Machine learning techniques, in particular ensemble methods offer increased accuracy for the prediction of MS disease course.
The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning techniques may offer more powerful means to predict disease course in MS patients. In our study, 724 patients from the Comprehensive Longitudinal Investigation in MS at Brigham and Women’s Hospital (CLIMB study) and 400 patients from the EPIC dataset, University of California, San Francisco, were included in the analysis. The primary outcome was an increase in Expanded Disability Status Scale (EDSS) ≥ 1.5 (worsening) or not (non-worsening) at up to 5 years after the baseline visit. Classification models were built using the CLIMB dataset with patients’ clinical and MRI longitudinal observations in first 2 years, and further validated using the EPIC dataset. We compared the performance of three popular machine learning algorithms (SVM, Logistic Regression, and Random Forest) and three ensemble learning approaches (XGBoost, LightGBM, and a Meta-learner L). A “threshold” was established to trade-off the performance between the two classes. Predictive features were identified and compared among different models. Machine learning models achieved 0.79 and 0.83 AUC scores for the CLIMB and EPIC datasets, respectively, shortly after disease onset. Ensemble learning methods were more effective and robust compared to standalone algorithms. Two ensemble models, XGBoost and LightGBM were superior to the other four models evaluated in our study. Of variables evaluated, EDSS, Pyramidal Function, and Ambulatory Index were the top common predictors in forecasting the MS disease course. Machine learning techniques, in particular ensemble methods offer increased accuracy for the prediction of MS disease course.
ArticleNumber 135
Author Zhao, Yijun
Bakshi, Rohit
Lokhande, Hrishikesh
Polgar-Turcsanyi, Mariann
Anderson, Mark
Chitnis, Tanuja
Weiner, Howard L.
Bove, Riley
Henry, Roland
Wang, Tong
Cree, Bruce
Author_xml – sequence: 1
  givenname: Yijun
  surname: Zhao
  fullname: Zhao, Yijun
  organization: Department of Computer and Information Science, Fordham University
– sequence: 2
  givenname: Tong
  surname: Wang
  fullname: Wang, Tong
  organization: Department of Computer and Information Science, Fordham University
– sequence: 3
  givenname: Riley
  surname: Bove
  fullname: Bove, Riley
  organization: University of California, SUMMIT Consortium, SUMMIT Consortium
– sequence: 4
  givenname: Bruce
  surname: Cree
  fullname: Cree, Bruce
  organization: University of California, SUMMIT Consortium, SUMMIT Consortium
– sequence: 5
  givenname: Roland
  surname: Henry
  fullname: Henry, Roland
  organization: University of California, SUMMIT Consortium, SUMMIT Consortium
– sequence: 6
  givenname: Hrishikesh
  surname: Lokhande
  fullname: Lokhande, Hrishikesh
  organization: Brigham Multiple Sclerosis Center, Ann Romney Center, Brigham and Women’s Hospital, Harvard Medical School
– sequence: 7
  givenname: Mariann
  orcidid: 0000-0002-1244-1802
  surname: Polgar-Turcsanyi
  fullname: Polgar-Turcsanyi, Mariann
  organization: SUMMIT Consortium, SUMMIT Consortium, Brigham Multiple Sclerosis Center, Ann Romney Center, Brigham and Women’s Hospital, Harvard Medical School
– sequence: 8
  givenname: Mark
  surname: Anderson
  fullname: Anderson, Mark
  organization: SUMMIT Consortium, SUMMIT Consortium, Brigham Multiple Sclerosis Center, Ann Romney Center, Brigham and Women’s Hospital, Harvard Medical School
– sequence: 9
  givenname: Rohit
  orcidid: 0000-0001-8601-5534
  surname: Bakshi
  fullname: Bakshi, Rohit
  organization: SUMMIT Consortium, SUMMIT Consortium, Brigham Multiple Sclerosis Center, Ann Romney Center, Brigham and Women’s Hospital, Harvard Medical School
– sequence: 10
  givenname: Howard L.
  surname: Weiner
  fullname: Weiner, Howard L.
  organization: SUMMIT Consortium, SUMMIT Consortium, Brigham Multiple Sclerosis Center, Ann Romney Center, Brigham and Women’s Hospital, Harvard Medical School
– sequence: 11
  givenname: Tanuja
  orcidid: 0000-0002-9897-4422
  surname: Chitnis
  fullname: Chitnis, Tanuja
  email: tchitnis@rics.bwh.harvard.edu
  organization: SUMMIT Consortium, SUMMIT Consortium, Brigham Multiple Sclerosis Center, Ann Romney Center, Brigham and Women’s Hospital, Harvard Medical School
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33083570$$D View this record in MEDLINE/PubMed
BookMark eNp9kk9rFTEUxYNUbK39Ai5kwI2b0fybJLMRpFR90KJguw6Z5L7XPGaSZ5IR-u3N67TadtFVQu45P07uva_RQYgBEHpL8EeCmfqUOZFctJjiFmPGVKteoCPKetUK1tGDB_dDdJLzFuMq5arn4hU6ZAwr1kl8hH6ehQzTMEIzgknBh02zS-C8LbmZ5rH4XS1lO0KK2efG-QwmQ2PjnOrhQ1Ouofl1dXGxumxymd3NG_RybcYMJ3fnMbr6enZ5-r09__FtdfrlvLUCi9JKjg1YZbkAZTgTnPdrSSXrqTODg76Tru9V52AQhhPLhOAOKwJYDrTriWHHaLVwXTRbvUt-MulGR-P17UNMG21S8TW5ZoNTRlFOzZpxGLqBSGodl5gT4wjHlfV5Ye3mYQJnIZRkxkfQx5Xgr_Um_tGyE1IqUgEf7gAp_p4hFz35bGEcTYA4Z015R3spBZZV-v6JdFt7GWqrNO2oUqJ-VVXVu4eJ_kW5H1wVqEVg62BygrW2vpji4z6gHzXBer8melkTXWevb9dE79n0ifWe_qyJLaZcxWED6X_sZ1x_AaKUzlY
CitedBy_id crossref_primary_10_1371_journal_pone_0306999
crossref_primary_10_3390_life11020122
crossref_primary_10_1007_s10439_022_02930_3
crossref_primary_10_1055_a_2530_1105
crossref_primary_10_3389_frai_2025_1478068
crossref_primary_10_3390_diagnostics12071771
crossref_primary_10_1186_s12967_022_03339_1
crossref_primary_10_1016_j_cmpb_2025_108624
crossref_primary_10_1007_s00415_023_12132_z
crossref_primary_10_1016_j_nicl_2022_103065
crossref_primary_10_3389_fneur_2023_1151326
crossref_primary_10_3390_app14146193
crossref_primary_10_1002_ana_26370
crossref_primary_10_1038_s41746_025_01863_0
crossref_primary_10_1186_s12911_022_02034_x
crossref_primary_10_1016_j_lanepe_2024_100978
crossref_primary_10_1007_s00415_024_12651_3
crossref_primary_10_3389_fneur_2023_1165267
crossref_primary_10_1021_acs_jcim_5c00465
crossref_primary_10_1186_s12916_024_03317_y
crossref_primary_10_3390_brainsci11111519
crossref_primary_10_1038_s41598_022_11361_y
crossref_primary_10_1080_01616412_2025_2532038
crossref_primary_10_1007_s00415_024_12507_w
crossref_primary_10_3389_frobt_2022_926255
crossref_primary_10_3390_diagnostics14131339
crossref_primary_10_1177_09612033221114805
Cites_doi 10.1177/1352458517726657
10.1001/archneurol.65.8.noc80042
10.1145/2939672.2939785
10.1093/brain/awh714
10.1007/3-540-45014-9_1
10.1093/brain/awg081
10.1016/S0893-6080(05)80023-1
10.1002/9781118548387
10.2307/2344614
10.1023/A:1010933404324
10.1016/j.ncl.2011.01.001
10.1016/S0140-6736(07)61194-5
10.1056/NEJMoa067597
10.1016/j.autrev.2006.02.012
10.1093/brain/112.1.133
10.1007/s100720070021
10.1212/WNL.33.11.1444
10.1093/brain/112.6.1419
ContentType Journal Article
Copyright The Author(s) 2020. corrected publication 2020
The Author(s) 2020.
The Author(s) 2020. corrected publication 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2020, corrected publication 2020
Copyright_xml – notice: The Author(s) 2020. corrected publication 2020
– notice: The Author(s) 2020.
– notice: The Author(s) 2020. corrected publication 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2020, corrected publication 2020
CorporateAuthor SUMMIT Investigators
CorporateAuthor_xml – name: SUMMIT Investigators
DBID C6C
AAYXX
CITATION
NPM
3V.
7RV
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1038/s41746-020-00338-8
DatabaseName Springer Nature Open Access Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
CrossRef

Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7RV
  name: Nursing & Allied Health Database
  url: https://search.proquest.com/nahs
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2398-6352
EndPage 8
ExternalDocumentID oai_doaj_org_article_3bd8a8242af34eb5b172cd47041ad140
PMC7567781
33083570
10_1038_s41746_020_00338_8
Genre Journal Article
GroupedDBID 0R~
53G
7RV
7X7
8FI
8FJ
AAJSJ
ABUWG
ACGFS
ACSMW
ADBBV
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
C6C
CCPQU
EBLON
EBS
EIHBH
FYUFA
GROUPED_DOAJ
HMCUK
HYE
M~E
NAO
NAPCQ
NO~
OK1
PGMZT
PIMPY
RNT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFFHD
CITATION
PHGZM
PHGZT
PPXIY
EJD
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c606t-740aec8c46e8a436449f727392dabde957d9985deb6a41c3664d081e07b2591a3
IEDL.DBID DOA
ISICitedReferencesCount 39
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000583291400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2398-6352
IngestDate Fri Oct 03 12:52:30 EDT 2025
Tue Nov 04 01:56:01 EST 2025
Wed Oct 01 13:12:06 EDT 2025
Tue Oct 07 06:49:55 EDT 2025
Mon Jul 21 05:47:41 EDT 2025
Sat Nov 29 02:05:37 EST 2025
Tue Nov 18 22:32:54 EST 2025
Fri Feb 21 02:39:51 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Multiple sclerosis
Language English
License The Author(s) 2020.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c606t-740aec8c46e8a436449f727392dabde957d9985deb6a41c3664d081e07b2591a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-8601-5534
0000-0002-9897-4422
0000-0002-1244-1802
OpenAccessLink https://doaj.org/article/3bd8a8242af34eb5b172cd47041ad140
PMID 33083570
PQID 2528863668
PQPubID 5061815
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_3bd8a8242af34eb5b172cd47041ad140
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7567781
proquest_miscellaneous_2452977607
proquest_journals_2528863668
pubmed_primary_33083570
crossref_citationtrail_10_1038_s41746_020_00338_8
crossref_primary_10_1038_s41746_020_00338_8
springer_journals_10_1038_s41746_020_00338_8
PublicationCentury 2000
PublicationDate 2020-10-16
PublicationDateYYYYMMDD 2020-10-16
PublicationDate_xml – month: 10
  year: 2020
  text: 2020-10-16
  day: 16
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle NPJ digital medicine
PublicationTitleAbbrev npj Digit. Med
PublicationTitleAlternate NPJ Digit Med
PublicationYear 2020
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References KrishnanCReduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosisArch. Neurol.2008651044105110.1001/archneurol.65.8.noc80042
WeinshenkerBGThe natural history of multiple sclerosis: a geographically based study: I. Clinical course and disabilityBrain198911213314610.1093/brain/112.1.133
Ke, G. et al. Lightgbm: A highly efficient gradient boosting decision tree. In Proc. of the 31st Conference on Neural Information Processing Systems (NIPS, Long Beach, CA, 2017).
QuinlanJRInduction of decision treesMach. Learn.1986181106
BoveRSUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohortsMult. Scler.2018241485149810.1177/1352458517726657
Nielsen, D. Tree Boosting with Xgboost-why Does Xgboost Win Every Machine Learning Competition? Master’s thesis, NTNU (2016).
FreundYSchapireRAbeNA short introduction to boostingJ.-Jpn. Soc. Artif. Intell.199914771780
Mowry, E. M. Natural history of multiple sclerosis: early prognostic factors. Neurol. Clin. 29, 279–292 (2011).
Chen, T. & Guestrin, C. Xgboost: A scalable tree boosting system. In Proc. of the 22nd acm sigkdd International Conference on Knowledge Discovery and Data Mining, 785–794 (KDD, New York, NY, 2016).
Amato, M. & Ponziani, G. A prospective study on the prognosis of multiple sclerosis. Neurol. Sci.21, S831–S838 (2000).
KurtzkeJFRating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)Neurology198333144414441:STN:280:DyaL2c%2FktValsQ%3D%3D10.1212/WNL.33.11.1444
GauthierSAGlanzBIMandelMWeinerHLA model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB studyAutoimmun. Rev.200655325361:CAS:528:DC%2BD28Xht12qtL3E10.1016/j.autrev.2006.02.012
KapposLEffect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT studyLancet20073703893971:CAS:528:DC%2BD2sXosFKktLc%3D10.1016/S0140-6736(07)61194-5
ConfavreuxCVukusicSAdeleinePEarly clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic processBrain200312677078210.1093/brain/awg081
BreimanLRandom forestsMach. Learn.20014553210.1023/A:1010933404324
CortesCVapnikVSupport-vector networksMach. Learn.199520273297
ConfavreuxCVukusicSAge at disability milestones in multiple sclerosisBrain200612959560510.1093/brain/awh714
Dietterich, T. G. Ensemble methods in machine learning. In Proc. of the International Workshop on Multiple Classifier Systems, Vol. 1857 (MCS, Cagliari, Italy, 2000).
Kasturi, S. N. XGBOOST vs LightGBM: Which Algorithm Wins the Race!!! https://towardsdatascience.com/lightgbm-vs-xgboost-which-algorithm-win-the-race-1ff7dd4917d (2019).
Hosmer, D. W. Jr, Lemeshow, S. & Sturdivant, R. X. Applied Logistic Regression, Vol. 398 (Wiley, Hoboken, 2013).
RenouxCNatural history of multiple sclerosis with childhood onsetN. Engl. J. Med.2007356260326131:CAS:528:DC%2BD2sXmslKjs7w%3D10.1056/NEJMoa067597
Longadge, R., Dongre, S. & Malik, L. Class imbalance problem in data mining: review. Int. J. Comp. Sci. Netw.2, 83 (2013).
WeinshenkerBGThe natural history of multiple sclerosis: a geographically based study: 2 predictive value of the early clinical courseBrain19891121419142810.1093/brain/112.6.1419
WolpertDHStacked generalizationNeural Netw.1992524125910.1016/S0893-6080(05)80023-1
NelderJAWedderburnRWGeneralized linear modelsJ. R. Stat. Soc. Ser. A (Gen.)197213537038410.2307/2344614
L Kappos (338_CR9) 2007; 370
BG Weinshenker (338_CR7) 1989; 112
R Bove (338_CR15) 2018; 24
JF Kurtzke (338_CR10) 1983; 33
338_CR22
338_CR21
338_CR20
C Krishnan (338_CR8) 2008; 65
338_CR5
JR Quinlan (338_CR14) 1986; 1
338_CR25
C Cortes (338_CR18) 1995; 20
L Breiman (338_CR19) 2001; 45
DH Wolpert (338_CR23) 1992; 5
338_CR1
C Confavreux (338_CR2) 2006; 129
JA Nelder (338_CR13) 1972; 135
Y Freund (338_CR24) 1999; 14
C Confavreux (338_CR3) 2003; 126
338_CR12
338_CR11
BG Weinshenker (338_CR6) 1989; 112
C Renoux (338_CR4) 2007; 356
SA Gauthier (338_CR16) 2006; 5
338_CR17
33299133 - NPJ Digit Med. 2020 Nov 20;3(1):155
References_xml – reference: FreundYSchapireRAbeNA short introduction to boostingJ.-Jpn. Soc. Artif. Intell.199914771780
– reference: BoveRSUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohortsMult. Scler.2018241485149810.1177/1352458517726657
– reference: ConfavreuxCVukusicSAge at disability milestones in multiple sclerosisBrain200612959560510.1093/brain/awh714
– reference: QuinlanJRInduction of decision treesMach. Learn.1986181106
– reference: Mowry, E. M. Natural history of multiple sclerosis: early prognostic factors. Neurol. Clin. 29, 279–292 (2011).
– reference: RenouxCNatural history of multiple sclerosis with childhood onsetN. Engl. J. Med.2007356260326131:CAS:528:DC%2BD2sXmslKjs7w%3D10.1056/NEJMoa067597
– reference: Nielsen, D. Tree Boosting with Xgboost-why Does Xgboost Win Every Machine Learning Competition? Master’s thesis, NTNU (2016).
– reference: ConfavreuxCVukusicSAdeleinePEarly clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic processBrain200312677078210.1093/brain/awg081
– reference: KrishnanCReduction of disease activity and disability with high-dose cyclophosphamide in patients with aggressive multiple sclerosisArch. Neurol.2008651044105110.1001/archneurol.65.8.noc80042
– reference: NelderJAWedderburnRWGeneralized linear modelsJ. R. Stat. Soc. Ser. A (Gen.)197213537038410.2307/2344614
– reference: Dietterich, T. G. Ensemble methods in machine learning. In Proc. of the International Workshop on Multiple Classifier Systems, Vol. 1857 (MCS, Cagliari, Italy, 2000).
– reference: Longadge, R., Dongre, S. & Malik, L. Class imbalance problem in data mining: review. Int. J. Comp. Sci. Netw.2, 83 (2013).
– reference: Ke, G. et al. Lightgbm: A highly efficient gradient boosting decision tree. In Proc. of the 31st Conference on Neural Information Processing Systems (NIPS, Long Beach, CA, 2017).
– reference: WeinshenkerBGThe natural history of multiple sclerosis: a geographically based study: 2 predictive value of the early clinical courseBrain19891121419142810.1093/brain/112.6.1419
– reference: KurtzkeJFRating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)Neurology198333144414441:STN:280:DyaL2c%2FktValsQ%3D%3D10.1212/WNL.33.11.1444
– reference: WeinshenkerBGThe natural history of multiple sclerosis: a geographically based study: I. Clinical course and disabilityBrain198911213314610.1093/brain/112.1.133
– reference: GauthierSAGlanzBIMandelMWeinerHLA model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB studyAutoimmun. Rev.200655325361:CAS:528:DC%2BD28Xht12qtL3E10.1016/j.autrev.2006.02.012
– reference: Hosmer, D. W. Jr, Lemeshow, S. & Sturdivant, R. X. Applied Logistic Regression, Vol. 398 (Wiley, Hoboken, 2013).
– reference: KapposLEffect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT studyLancet20073703893971:CAS:528:DC%2BD2sXosFKktLc%3D10.1016/S0140-6736(07)61194-5
– reference: BreimanLRandom forestsMach. Learn.20014553210.1023/A:1010933404324
– reference: WolpertDHStacked generalizationNeural Netw.1992524125910.1016/S0893-6080(05)80023-1
– reference: Chen, T. & Guestrin, C. Xgboost: A scalable tree boosting system. In Proc. of the 22nd acm sigkdd International Conference on Knowledge Discovery and Data Mining, 785–794 (KDD, New York, NY, 2016).
– reference: Amato, M. & Ponziani, G. A prospective study on the prognosis of multiple sclerosis. Neurol. Sci.21, S831–S838 (2000).
– reference: Kasturi, S. N. XGBOOST vs LightGBM: Which Algorithm Wins the Race!!! https://towardsdatascience.com/lightgbm-vs-xgboost-which-algorithm-win-the-race-1ff7dd4917d (2019).
– reference: CortesCVapnikVSupport-vector networksMach. Learn.199520273297
– volume: 24
  start-page: 1485
  year: 2018
  ident: 338_CR15
  publication-title: Mult. Scler.
  doi: 10.1177/1352458517726657
– volume: 65
  start-page: 1044
  year: 2008
  ident: 338_CR8
  publication-title: Arch. Neurol.
  doi: 10.1001/archneurol.65.8.noc80042
– volume: 1
  start-page: 81
  year: 1986
  ident: 338_CR14
  publication-title: Mach. Learn.
– ident: 338_CR22
  doi: 10.1145/2939672.2939785
– volume: 129
  start-page: 595
  year: 2006
  ident: 338_CR2
  publication-title: Brain
  doi: 10.1093/brain/awh714
– volume: 20
  start-page: 273
  year: 1995
  ident: 338_CR18
  publication-title: Mach. Learn.
– ident: 338_CR12
– ident: 338_CR21
  doi: 10.1007/3-540-45014-9_1
– volume: 126
  start-page: 770
  year: 2003
  ident: 338_CR3
  publication-title: Brain
  doi: 10.1093/brain/awg081
– volume: 5
  start-page: 241
  year: 1992
  ident: 338_CR23
  publication-title: Neural Netw.
  doi: 10.1016/S0893-6080(05)80023-1
– ident: 338_CR25
– ident: 338_CR20
  doi: 10.1002/9781118548387
– volume: 135
  start-page: 370
  year: 1972
  ident: 338_CR13
  publication-title: J. R. Stat. Soc. Ser. A (Gen.)
  doi: 10.2307/2344614
– volume: 45
  start-page: 5
  year: 2001
  ident: 338_CR19
  publication-title: Mach. Learn.
  doi: 10.1023/A:1010933404324
– ident: 338_CR1
  doi: 10.1016/j.ncl.2011.01.001
– ident: 338_CR11
– ident: 338_CR17
– volume: 370
  start-page: 389
  year: 2007
  ident: 338_CR9
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)61194-5
– volume: 356
  start-page: 2603
  year: 2007
  ident: 338_CR4
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa067597
– volume: 5
  start-page: 532
  year: 2006
  ident: 338_CR16
  publication-title: Autoimmun. Rev.
  doi: 10.1016/j.autrev.2006.02.012
– volume: 14
  start-page: 771
  year: 1999
  ident: 338_CR24
  publication-title: J.-Jpn. Soc. Artif. Intell.
– volume: 112
  start-page: 133
  year: 1989
  ident: 338_CR6
  publication-title: Brain
  doi: 10.1093/brain/112.1.133
– ident: 338_CR5
  doi: 10.1007/s100720070021
– volume: 33
  start-page: 1444
  year: 1983
  ident: 338_CR10
  publication-title: Neurology
  doi: 10.1212/WNL.33.11.1444
– volume: 112
  start-page: 1419
  year: 1989
  ident: 338_CR7
  publication-title: Brain
  doi: 10.1093/brain/112.6.1419
– reference: 33299133 - NPJ Digit Med. 2020 Nov 20;3(1):155
SSID ssj0002048946
Score 2.35389
Snippet The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning techniques may offer more powerful means to predict...
Abstract The rate of disability accumulation varies across multiple sclerosis (MS) patients. Machine learning techniques may offer more powerful means to...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 135
SubjectTerms 692/617/375/1411/1666
692/617/375/1666
Algorithms
Biomedicine
Biotechnology
Datasets
Digital technology
Health informatics
Machine learning
Medicine
Medicine & Public Health
Multiple sclerosis
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7BFqFeeD8CBRmJG0SNYyd2ToiirUCC1QoVqTfLsZ2yUkm2my2_n5mss9Xy6IVrbEd2Zsb5xjP-BuB1LXiZ-5CljbAhlbwpUuuDS5WzTWULUTTNwK7_Wc1m-vS0mscDtz6mVY574rBR-87RGflhXuRal6Is9bvlRUpVoyi6Gkto3IQ9YiqTE9g7ms7mX7enLERLW8ky3pbJhD7sJWJwyrulC9Xon6V65480EPf_DW3-mTT5W-R0-CEd3_3fpdyDOxGKsvcb3bkPN0L7AG5_icH2hzCftn34UZ8HFktLnLHlilrXPRvzEFmPQ3FZi57FUA9zHeWFsEXLEFsy2rU_nbCBxfYRfDuennz4mMYCDKlDv2adKpnZ4LSTZdBWCoROVUN4p8q9rX2oCuXRWyt8qEsrucMVSY8QI2SqRq-KW_EYJm3XhqfAsiBspj0XPnCptLMVD-htKouApapznwAfhWBcZCenIhnnZoiSC202gjMoODMIzugE3mzHLDfcHNf2PiLZbnsSr_bwoFudmWimRtReW42wxTZChrqoEd85L1UmufXoiyZwMIrURGPvzZU8E3i1bUYzpdiLbUN3iX0owK1UmakEnmwUaTsTIQgHK3y52lGxnanutrSL7wMVuCqIAJAn8HZUxqtp_ftTPLt-Fc9hPyf7oLyd8gAm69VleAG33M_1ol-9jCb2C-pjLfU
  priority: 102
  providerName: ProQuest
Title Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study
URI https://link.springer.com/article/10.1038/s41746-020-00338-8
https://www.ncbi.nlm.nih.gov/pubmed/33083570
https://www.proquest.com/docview/2528863668
https://www.proquest.com/docview/2452977607
https://pubmed.ncbi.nlm.nih.gov/PMC7567781
https://doaj.org/article/3bd8a8242af34eb5b172cd47041ad140
Volume 3
WOSCitedRecordID wos000583291400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2398-6352
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002048946
  issn: 2398-6352
  databaseCode: DOA
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2398-6352
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002048946
  issn: 2398-6352
  databaseCode: M~E
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 2398-6352
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002048946
  issn: 2398-6352
  databaseCode: 7RV
  dateStart: 20181201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2398-6352
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002048946
  issn: 2398-6352
  databaseCode: BENPR
  dateStart: 20181201
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Health & Medical Collection
  customDbUrl:
  eissn: 2398-6352
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002048946
  issn: 2398-6352
  databaseCode: 7X7
  dateStart: 20181201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2398-6352
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002048946
  issn: 2398-6352
  databaseCode: PIMPY
  dateStart: 20181201
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BQagXxLuhZWUkbhA1jp3YObZoKyrRVVQVtJwsx3bKVm222mz5_Ywd79LleeESKbGdTMZj-xvN-DPAm4bRMrcuS1umXcppW6TaOpMKo9tKF6xo28Cu_1FMJnI6repbR335nLCBHnhQ3D5rrNQSFxLdMu6aosEV11guMk61Re_Az76Iem45UxchvMZlxcu4SyZjcr_niL19vq3fSI1-WSo3VqJA2P87lPlrsuRPEdOwEB09gocRQZKDQfLHcMd1T-DBSYyRP4V63PXuqrl0JJ4IcU6uF7502ZNV-iDpsSlKNetJjNAQM_fpHGTWEYSExE-2x2ckkM8-g09H47P3H9J4bkJq0B1ZpoJn2hlpeOmk5gwRT9V6mFLlVjfWVYWw6GQV1jWl5tSwsuQWkYHLRIPOENXsOWx1887tAMkc05m0lFlHuZBGV9Shkyg04oyqyW0CdKVDZSKpuD_b4lKF4DaTatC7Qr2roHclE3i7bnM9UGr8tfah75p1TU-HHR6gkahoJOpfRpLA3qpjVRyjvcqLXMoS_x6_8XpdjKPLh0x05-Y3WMfHpYUoM5HAi8EO1pIw5uGrwJeLDQvZEHWzpJt9DQzeovC8fTSBdytb-iHWn1Xx8n-oYhe2cz8IfFJOuQdby8WNewX3zbflrF-M4K44_eyvUxGucgT3DseT-nQUxhfe1ccn9ZfvJ-8kag
linkProvider Directory of Open Access Journals
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoAL70eggJHgRKPGsRM7B4R4tOqq21WFFtSbcWynrFSSZbMF8af4jYzzqpZHbz1wjZ3EcT7PfOMZzwA8yxlNY-uisGDahZwWSaitM6Ewush0wpKiaLLrj8VkIg8Ps4M1-NmfhfFhlb1MbAS1rYzfI9-Kk1jKlKWpfDX_GvqqUd672pfQaGGx5358R5Otfjl6h__3eRzvbE_f7oZdVYHQIFlfhoJH2hlpeOqk5gz5QFZ4JZ7FVufWZYmwaIIk1uWp5tTgG7lFvekikaOpQDXD516AiyjHqQ8hE-8_Dns6PgluxtPubE7E5FbNkfH7KF9_fButwVCu6L-mTMDfuO2fIZq_-Wkb9bdz_X-buBtwrSPa5HW7Mm7CmitvweX9LpTgNhxsl7X7kh870hXOOCLzhW9d1qSPsiQ13orTOKtJ58gipvJRL2RWEmTOxOuk0ZQ0OXrvwIdz-Z67sF5WpbsPJHJMR9JSZh3lQhqdUYe2tNBIx7I8tgHQ_qcr0-Ve9yVAjlUTA8CkaoGiECiqAYqSAbwY7pm3mUfO7P3GY2no6bOGNxeqxZHqhJBiuZVaIinTBeMuT3Jkr8ZyEXGqLVraAWz0EFKdKKvVKX4CeDo0oxDyniVduuoE-3j3vRBpJAK41wJ3GAljnuULfLhYgfTKUFdbytnnJtG5SHx6QxrAZg_-02H9eyoenP0VT-DK7nR_rMajyd5DuBr7tekjlNINWF8uTtwjuGS-LWf14nGzuAl8Ou9F8QszBoiD
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ensemble+learning+predicts+multiple+sclerosis+disease+course+in+the+SUMMIT+study&rft.jtitle=NPJ+digital+medicine&rft.au=Zhao%2C+Yijun&rft.au=Wang%2C+Tong&rft.au=Bove%2C+Riley&rft.au=Cree%2C+Bruce&rft.date=2020-10-16&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2398-6352&rft.volume=3&rft.issue=1&rft_id=info:doi/10.1038%2Fs41746-020-00338-8&rft.externalDocID=10_1038_s41746_020_00338_8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2398-6352&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2398-6352&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2398-6352&client=summon